Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.

Published byKristin Shepherd Modified over 8 years ago

Similar presentations

Presentation on theme: "Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology."— Presentation transcript:

1 Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology and Biostatistics Philadelphia, PA CCEB

2 Overview of Talk Clinical approach to the diagnosis of acute respiratory tract infections Case example: Evaluation of diagnostic tests for pneumococcal pneumonia Implications for the development and application of SARS diagnostic tests

3 Applications of Diagnostic Testing Physician Perspective: Determining need for antimicrobial Rx Targeting antimicrobial Rx Risk stratification for site of care Public Health Perspective: Disease surveillance Infection control Clinical studies

4 Characteristics of Diagnostic Tests Physician perspective: Rapid detection Bedside capability Examples: –Antigen assays –DNA amplification Public Health perspective: Time insensitive Centralized testing Examples: –Micro cultures –Serology

5 Diagnostic TestPathogen Rx Alternative Dx 0100 Probability of Specific Pathogen: No Test/Test Test/Treat Determining the Optimal Use of Diagnostic Tests for Patients with Acute Respiratory Infections XY Adapted from Pauker and Kassirer. NEJM. 1980

6 Calculating the No Test/Test Threshold (1-Specificity) x R ((1-Specificity) x R) + (Sensitivity x B) Where R=Risk and B=Benefit of Treatment

7 Calculating the Test/Treatment Threshold Specificity x R (Specificity x R)+((1-Sensitivity) x B) Where R=Risk and B=Benefit of Treatment

8 Diagnostic TestPathogen Rx Alternative Dx 0100 Probability of S. pneumoniae: No Test/Test Test/Treat Diagnostic Test Thresholds for Patients with Suspected Pneumococcal Pneumonia XY

9 Factors Influencing the Clinical Decision to Use a Diagnostic Test Pretest probability of disease Test costs (clinical and financial) Test sensitivity and specificity Treatment risks and benefits

10 Pretest Probability Population based estimates Modified for individual patient characteristics –Presenting symptoms –Presenting signs Modified for temporal and geographic trends

11 Estimating the probability of pneumonia in patients with acute cough illness

12 Pretest Probability Population based estimates Modified for individual patient characteristics –Probability of pneumonia –Probability of pneumococcal pneumonia Modified for temporal and geographic trends

13 Identifying Pneumonia based on Signs and Symptoms

14 Identifying the Pathogen based on History and Physical Exam Once the diagnosis of pneumonia is established, the H&P is of little value in targeting antimicrobial therapy Both IDSA and ATS guidelines advise against targeted therapy based on H&P Clinical associations of signs and symptoms are rarely sufficient to guide therapy

15 Pretest Probability of Specific Pathogens in Patients with ARIs 30 million cough visits per year in the US 5% of patients with ARIs will have CAP 30% - 50% of patients with CAP have S. pneumoniae 1% of cough patients have pneumococcal pneumonia

16 Factors Influencing the Clinical Decision to Use a Diagnostic Test Pretest probability of disease Test costs (clinical and financial) Test sensitivity and specificity Treatment risks and benefits

17 Accuracy of Rapid Diagnostic Tests PathogenAssaySensitivitySpecificity S. pneumoniaeUrine antigen 86%94% S. pneumoniaeGram stain60%85% InfluenzaSputum antigen 85%95%

18 Estimating the Risks and Benefits of Treatment For most antimicrobial drugs, placebo controlled data on efficacy is missing For most antimicrobial drugs, premarketing information on risk is limited

19 Mortality Assessment in Pneumonia 0 10 20 30 40 50 60 70 Inpatients and Outpatients Inpatients Only Bacteremic Patients ICU Patients Pre-antibiotics Antibiotics

20 Testing thresholds for Pneumococcal Detection using Gram Stain Treatment benefit 10-15% Treatment risk 1% No Test/Test threshold: 2% Test/Treat threshold: 14%

21 Diagnostic TestPathogen Rx Alternative Dx 0100 Probability of S. pneumoniae: No Test/Test Test/Treat Diagnostic Test Thresholds for Patients with Suspected Pneumococcal Pneumonia 214

22 Lessons learned from the pneumococcal pneumonia example Until the pretest probability is > 1%, diagnostic testing is unlikely to be indicated in routine practice Unless the diagnostic test has excellent operating characteristics, the testing window will be narrow. Effective treatments for high risk illnesses have low thresholds unless treatment risk is high.

23 Identifying the Optimal Clinical Settings for a Diagnostic Test PreTest Probability PostTest Probability 0100 0 + Result - Result

24 PCR/EIAIntervention Alternative Dx 0100 Probability of SARS: No Test/Test Test/Treat Determining the Optimal Use of Diagnostic Tests for Patients with Suspected SARS XY

25 SARS Case Definition: A potential population for diagnostic testing Severe respiratory illness: –Cough illness with fever –Pneumonia/ARDS on CXR Exposure history –Travel –Close contact

26 SARS Diagnosis in Primary Care We must emphasize importance of local surveillance and disease reporting. Absent local cases, diagnostic testing will not be supported without epidemiological exposures Given competing respiratory pathogens, it is unlikely that signs and symptoms will further modify pretest probability

Download ppt "Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology."

Similar presentations

CQ Deng, PhD PPD Development Research Triangle Park, NC 27560

CQ Deng, PhD PPD Development Research Triangle Park, NC 27560
Nick Curry, MD, MPH Infectious Diseases Prevention Section

Nick Curry, MD, MPH Infectious Diseases Prevention Section
Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.

Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
Evidence-Based Diagnosis Part I: Introduction to diagnosis Mark H. Ebell MD, MS Associate Professor Dept of Epidemiology and Biostatistics Co-Director,

Evidence-Based Diagnosis Part I: Introduction to diagnosis Mark H. Ebell MD, MS Associate Professor Dept of Epidemiology and Biostatistics Co-Director,
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.

Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
12 June 2004Clinical algorithms in public health1 Seminar on “Intelligent data analysis and data mining – Application in medicine” Research on poisonings.

12 June 2004Clinical algorithms in public health1 Seminar on “Intelligent data analysis and data mining – Application in medicine” Research on poisonings.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP

Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.

H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.

ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.

Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.

1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
Pneumonia Sapna Bamrah, MD CDC

Pneumonia Sapna Bamrah, MD CDC
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.

G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.

Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.

NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.

Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Module 6: Routine HIV Testing of TB Patients. Learning Objectives Explain why TB suspects and patients should be routinely tested for HIV Summarize the.

Module 6: Routine HIV Testing of TB Patients. Learning Objectives Explain why TB suspects and patients should be routinely tested for HIV Summarize the.

Similar presentations

Ads by Google